Last reviewed · How we verify
F-18 florbetapir
F-18 florbetapir is a Small molecule drug developed by The Cleveland Clinic. It is currently FDA-approved. Also known as: Amyvid, Florbetapir-fluorine-18, 18F-AV-45.
At a glance
| Generic name | F-18 florbetapir |
|---|---|
| Also known as | Amyvid, Florbetapir-fluorine-18, 18F-AV-45 |
| Sponsor | The Cleveland Clinic |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Alzheimer's Disease Neuroimaging Initiative 4
- Diagnostic Utility of F-18 Florbetapir PET/MR in Peripheral Nerve Amyloidosis (PHASE1, PHASE2)
- Biomarker Exploration in Aging, Cognition and Neurodegeneration (PHASE3)
- Imaging Cardiac Amyloidosis: A Pilot Study Using F-18 Florbetapir Positron Emission Tomography (PHASE4)
- Molecular Imaging of Primary Amyloid Cardiomyopathy (NA)
- A Study of Health Care Use and Costs in Participants With Early Stage Alzheimer's Disease (AD)
- Neuronavigation-guided FUS-induced BBB Opening in Alzheimer's Disease Patients and Its Effects on Brain Amyloid and Tau (PHASE1)
- Effects of Brain Beta-Amyloid on Postoperative Cognition (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- F-18 florbetapir CI brief — competitive landscape report
- F-18 florbetapir updates RSS · CI watch RSS
- The Cleveland Clinic portfolio CI
Frequently asked questions about F-18 florbetapir
What is F-18 florbetapir?
F-18 florbetapir is a Small molecule drug developed by The Cleveland Clinic.
Who makes F-18 florbetapir?
F-18 florbetapir is developed and marketed by The Cleveland Clinic (see full The Cleveland Clinic pipeline at /company/the-cleveland-clinic).
Is F-18 florbetapir also known as anything else?
F-18 florbetapir is also known as Amyvid, Florbetapir-fluorine-18, 18F-AV-45.
What development phase is F-18 florbetapir in?
F-18 florbetapir is FDA-approved (marketed).
Related
- Manufacturer: The Cleveland Clinic — full pipeline
- Also known as: Amyvid, Florbetapir-fluorine-18, 18F-AV-45
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing